Novel rel- (5R,6S,7S)-2-oxo-5-phenyl-7-aryl(hetaryl)-3,7-dihydro-2H-thiopyrano [2,3-d]thiazole-6-carboxylic acid amides were synthesized in a hetero-DielsAlder reaction with a series of cinnamic acid amides. The synthesized compounds were tested for their anticancer activity in vitro in the standard National Cancer Institute 60 cancer cell line assay. Promising compounds 3e, 3g, and 3h with moderate antitumor activity were identified among the synthesized series.
Introduction
Investigations of thiopyrano [2,3-d] thiazole derivatives, the isosteric mimics of biologically active 5-ylidene-4-thiazolidinones, led to the synthesis of compounds with anticancer, antitrypanosomal, and antimycobacterial properties which can provide an opportunity to further study and explore the pharmacological activity of these heterocyclic systems in the future [1] [2] [3] [4] [5] [6] [7] [8] [9] [10] [11] [12] [13] . We decided to combine in a single heterocyclic system the thiazolidinone moiety and a fragment of cinnamic acid (Sch. 1). Cinnamic acid and its derivatives exhibit antitumor, antimicrobial, antifungal action and act as histamine H 3 -receptor antagonists [14] [15] [16] . Consequently, we have synthesized thiopyrano [2,3-d] thiazoles using cinnamic acid amides as the dienophile in the reaction of hetero-Diels-Alder.
In addition, heterodiene synthesis allows the fixing of the biologically important 4-thiazolidinone fragment in a rigid fused system, preserving its biological activity. Moreover, the combination of thiazole and thiopyran in a fused heterosystem is a precondition for creating ligand-target binding and enhances the potential selectivity to biotargets. This approach suggests the critical impact of the substituent on the biological activity with particular selectivity to various cancer cell lines. 
Results and Discussion

Chemistry
The starting 5-aryl(hetaryl)idene-4-thioxo-2-thiazolidinones 1a-d were obtained by the treatment of 4-thioxo-2-thiazolidinone with the appropriate aldehydes in glacial acetic acid with a catalytic amount of fused sodium acetate [4, 12] . The cinnamic acid amides were synthesized by the interaction of the corresponding cinnamic acid chloride with 4-substituted anilines, morpholine, and 2-aminopyridine in anhydrous dioxane. The heteroDiels-Alder reaction of 2a-f with 5-aryl(hetaryl)idene-4-thioxo-2-thiazolidinones 1a-d yielded a series of novel rel- 
Biological Activity
The synthesized rel-(5R,6S,7S)-2-oxo-5-phenyl-7-aryl(hetaryl)-3,7-dihydro-2H-thiopyrano-
thiazole-6-carboxylic acid amides were selected by the National Cancer Institute (NCI) Developmental Therapeutic Program (www.dtp.nci.nih.gov) for the in vitro cell line screening to investigate their anticancer activity. Anticancer assays were performed according to the NCI protocol, which is described elsewhere [5] [6] [7] 17] . The compounds were evaluated for antitumor activity against 60 cancer lines at a 10 µM concentration. The human tumor cell lines were derived from nine different cancer types: leukemia, melanoma, lung, colon, CNS, ovarian, renal, prostate, and breast cancers. The screening results are shown in Table 1 .
The tested compounds showed different levels of activity on various cancer cell lines. The most active compounds were 3e, 3g, 3h, being highly potent in certain lines of cancer, but they had almost no activity in others. 
Experimental
Chemistry
All materials were purchased from Merck, Sigma-Aldrich, or Lancaster and were used without purification. 5-Aryl(hetaryl)idene-4-thioxo-2-thiazolidinones 1a-d were employed as starting materials and prepared according to the method described previously [4, 12] . Melting points were determined in open capillary tubes and were uncorrected. The elemental analyses (C, H, N) were performed using the Perkin-Elmer 2400 CHN analyzer and were within 0.4% of the theoretical values. The 
General Procedure of the Hetero-Diels-Alder Reaction Affording 3a-m
A mixture of appropriate 5-aryl(hetaryl)idene-4-thioxo-2-thiazolidinone (5 mmol) and cinnamic acid amide (5.5 mmol) was refluxed for 4-7 h with a catalytic amount of hydroquinone (2-3 mg) in 15 ml of glacial acetic acid and left overnight at room temperature. The obtained solid products were collected by filtration, washed with water, methanol (5-10 ml), diethyl ether, and recrystallized from the appropriate solvent.
rel-(5R,6S,7S)-N-(4-Chlorophenyl)-7-(4-hydroxyphenyl)-2-oxo-5-phenyl-3,5,6,7-tetrahydro-2H-thiopyrano[2,3-d][1,3]thiazole-6-carboxamide (3a)
Yield: 59%, mp 234-236°C (EtOH). 
rel-(5R,6S,7S)-7-(4-Chlorophenyl)-N-(4-hydroxyphenyl)-2-oxo-5-phenyl-3,5,6,7-tetrahydro-2H-thiopyrano[2,3-d][1,3]thiazole-6-carboxamide (3b)
Yield: 57%, mp 220-224°C (EtOH). 
rel-(5R,6S,7S)-7-(4-Methylphenyl)-2-oxo-5-phenyl-N-(4-sulfamoylphenyl)-3,5,6,7-tetrahydro-2H-thiopyrano[2,3-d][1,3]thiazole-6-carboxamide (3c)
Yield: 60%, mp 188-190°C (EtOH). 
rel-(5R,6S,7S)-7-(4-Chlorophenyl)-2-oxo-5-phenyl-N-(4-sulfamoylphenyl)-3,5,6,7-tetrahydro-2H-thiopyrano[2,3-d][1,3]thiazole-6-carboxamide (3d)
Yield: 68%, mp 182-184°C (EtOH). 
rel-(5R,6S,7S)-N,7-Bis(4-chlorophenyl)-2-oxo-5-phenyl-3,5,6,7-tetrahydro-2H-thiopyrano[2,3-d][1,3]thiazole-6-carboxamide (3e)
Yield: 65%, mp 216-218°C (EtOH). 
rel-(5R,6S,7S)-N-(4-Chlorophenyl)-7-(4-methylphenyl)-2-oxo-5-phenyl-3,5,6,7-tetrahydro-2H-thiopyrano[2,3-d][1,3]thiazole-6-carboxamide (3f)
Yield: 75%, mp 200-202°C (EtOH). 
rel-(5R,6S,7S)-7-(4-Chlorophenyl)-N-(4-methylphenyl)-2-oxo-5-phenyl-3,5,6,7-tetrahydro-2H-thiopyrano[2,3-d][1,3]thiazole-6-carboxamide (3g)
Yield: 70%, mp 234-236°C (EtOH). 
rel-(5R,6S,7S)-N,7-Bis(4-methylphenyl)-2-oxo-5-phenyl-3,5,6,7-tetrahydro-2H-thiopyrano[2,3-d][1,3]thiazole-6-carboxamide (3h)
Yield: 56%, mp 230-232°C (EtOH). 
rel-(5R,6S,7S)-N-(4-Chlorophenyl)-2-oxo-5-phenyl-7-(thiophen-2-yl)-3,5,6,7-tetrahydro-2H-thiopyrano[2,3-d][1,3]thiazole-6-carboxamide (3i)
Yield: 84%, mp 208-210°C (EtOH). 
rel-(5R,6S,7S)-7-(4-Chlorophenyl)-2-oxo-5-phenyl-N-(pyridin-2-yl)-3,5,6,7-tetrahydro-2H-thiopyrano[2,3-d][1,3]thiazole-6-carboxamide (3j)
Yield: 56%, mp 178-180°C (AcOH). 
rel-(5R,6S,7S)-7-(4-Methylphenyl)-6-(morpholin-4-ylcarbonyl)-5-phenyl-3,5,6,7-tetrahydro-2H-thiopyrano[2,3-d][1,3]thiazol-2-one (3m)
Yield: 77%, mp 176-178°C (PhH). 
Cytotoxic Activity Against Malignant Human Tumor Cells
An anticancer in vitro assay was performed on the human tumor cell lines panel derived from nine neoplastic diseases, in accordance with the protocol of the Drug Evaluation Branch, National Cancer Institute, Bethesda [5] [6] [7] 17] . The tested compounds were added to the culture at a single concentration (10 −5 M) and the cultures were incubated for 48 h. Endpoint determinations were made with a protein binding dye, sulforhodamine B (SRB). Results for each tested compound were reported as the percent of growth of the treated cells when compared to the untreated control cells. The growth percentage was evaluated spectrophotometrically versus controls not treated with the test agents.
